Joincare Pharmaceutical Group Industry600380.SHValuation Analysis

As of Oct 19, 2026, Joincare Pharmaceutical Group Industry (600380.SH) trades at a P/E of 15.40x, P/B of 1.22x, P/S of 1.40x, and a dividend yield of 2.18%.
Longitudinal percentile comparison: P/E sits at the 36th percentile over the trailing 10Y window (vs. 62nd percentile over 3Y); P/B sits at the 6th percentile over the trailing 10Y window (vs. 18th percentile over 3Y); P/S sits at the 54th percentile over the trailing 10Y window (vs. 82nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 10th percentile within its industry and the 15th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.11%, ranking at the 75th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 30.0 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 2.18% comes from cash dividends, with an implied ~0.93% from buybacks — a fairly balanced mix of both channels. Joincare Pharmaceutical Group Industry operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.